198 related articles for article (PubMed ID: 33833411)
1. Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities.
Carmignac V; Mignot C; Blanchard E; Kuentz P; Aubriot-Lorton MH; Parker VER; Sorlin A; Fraitag S; Courcet JB; Duffourd Y; Rodriguez D; Knox RG; Polubothu S; Boland A; Olaso R; Delepine M; Darmency V; Riachi M; Quelin C; Rollier P; Goujon L; Grotto S; Capri Y; Jacquemont ML; Odent S; Amram D; Chevarin M; Vincent-Delorme C; Catteau B; Guibaud L; Arzimanoglou A; Keddar M; Sarret C; Callier P; Bessis D; Geneviève D; Deleuze JF; Thauvin C; Semple RK; Philippe C; Rivière JB; Kinsler VA; Faivre L; Vabres P
Genet Med; 2021 Aug; 23(8):1484-1491. PubMed ID: 33833411
[TBL] [Abstract][Full Text] [Related]
2. Recurrent mosaic MTOR c.5930C > T (p.Thr1977Ile) variant causing megalencephaly, asymmetric polymicrogyria, and cutaneous pigmentary mosaicism: Case report and review of the literature.
Handoko M; Emrick LT; Rosenfeld JA; Wang X; Tran AA; Turner A; Belmont JW; ; Lee BH; Bacino CA; Chao HT
Am J Med Genet A; 2019 Mar; 179(3):475-479. PubMed ID: 30569621
[TBL] [Abstract][Full Text] [Related]
3. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
[TBL] [Abstract][Full Text] [Related]
4. Total Hemi-overgrowth in Pigmentary Mosaicism of the (Hypomelanosis of) Ito Type: Eight Case Reports.
Pavone V; Signorelli SS; Praticò AD; Corsello G; Savasta S; Falsaperla R; Pavone P; Sessa G; Ruggieri M
Medicine (Baltimore); 2016 Mar; 95(10):e2705. PubMed ID: 26962770
[TBL] [Abstract][Full Text] [Related]
5. Monogenic causes of pigmentary mosaicism.
Saida K; Chong PF; Yamaguchi A; Saito N; Ikehara H; Koshimizu E; Miyata R; Ishiko A; Nakamura K; Ohnishi H; Fujioka K; Sakakibara T; Asada H; Ogawa K; Kudo K; Ohashi E; Kawai M; Abe Y; Tsuchida N; Uchiyama Y; Hamanaka K; Fujita A; Mizuguchi T; Miyatake S; Miyake N; Kato M; Kira R; Matsumoto N
Hum Genet; 2022 Nov; 141(11):1771-1784. PubMed ID: 35503477
[TBL] [Abstract][Full Text] [Related]
6. Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities.
Mroske C; Rasmussen K; Shinde DN; Huether R; Powis Z; Lu HM; Baxter RM; McPherson E; Tang S
BMC Med Genet; 2015 Nov; 16():102. PubMed ID: 26542245
[TBL] [Abstract][Full Text] [Related]
7. Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation.
Hadouiri N; Darmency V; Guibaud L; Arzimanoglou A; Sorlin A; Carmignac V; Rivière JB; Huet F; Luu M; Bardou M; Thauvin-Robinet C; Vabres P; Faivre L
Eur J Med Genet; 2020 Nov; 63(11):104036. PubMed ID: 32805448
[TBL] [Abstract][Full Text] [Related]
8. Hypomelanosis of Ito with a trisomy 2 mosaicism: a case report.
Ponti G; Pellacani G; Tomasi A; Percesepe A; Guarneri C; Guerra A; Mandel VD; Kisla E; Cevikel P; Neri C; Menozzi C; Seidenari S
J Med Case Rep; 2014 Oct; 8():333. PubMed ID: 25301139
[TBL] [Abstract][Full Text] [Related]
9. [Hypomelanosis of Ito in a girl with Trisomy 13 mosaicism: a cytogenetic study].
Ronger S; Till M; Kanitakis J; Balme B; Thomas L
Ann Dermatol Venereol; 2003 Nov; 130(11):1033-8. PubMed ID: 14724538
[TBL] [Abstract][Full Text] [Related]
10. mTOR mutations in Smith-Kingsmore syndrome: Four additional patients and a review.
Gordo G; Tenorio J; Arias P; Santos-Simarro F; García-Miñaur S; Moreno JC; Nevado J; Vallespin E; Rodriguez-Laguna L; de Mena R; Dapia I; Palomares-Bralo M; Del Pozo Á; Ibañez K; Silla JC; Barroso E; Ruiz-Pérez VL; Martinez-Glez V; Lapunzina P
Clin Genet; 2018 Apr; 93(4):762-775. PubMed ID: 28892148
[TBL] [Abstract][Full Text] [Related]
11. Correspondence on "Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities," by Carmignac et al.
Resta N; Calabrese O; Grossi V; Lugli L; Simone C; Ranieri C; Piglionica M; Lepore Signorile M; Rossi K; Carli D; Mussa A
Genet Med; 2021 Nov; 23(11):2223-2224. PubMed ID: 34234302
[No Abstract] [Full Text] [Related]
12. Allelic heterogeneity in a patient with postzygotic MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities.
Engel C; Chevarin M; Piard J; Abad M; Thomas Q; Carmignac V; Duffourd Y; Lemesle-Martin M; Tarris G; Thauvin-Robinet C; Vabres P; Faivre L; Kuentz P
Clin Genet; 2024 May; 105(5):581-583. PubMed ID: 38379111
[TBL] [Abstract][Full Text] [Related]
13. A new case of Smith-Kingsmore syndrome with somatic MTOR pathogenic variant expands the phenotypic spectrum to lateralized overgrowth.
Carli D; Ferrero GB; Fusillo A; Coppo P; La Selva R; Zinali F; Cardaropoli S; Ranieri C; Iacoviello M; Resta N; Mussa A
Clin Genet; 2021 May; 99(5):719-723. PubMed ID: 33506498
[TBL] [Abstract][Full Text] [Related]
14. Hypomelanosis of Ito: pigmentary mosaicism with immature melanosome in keratinocytes.
Devillers C; Quatresooz P; Hermanns-Lê T; Szepetiuk G; Lemaire R; Piérard-Franchimont C; Piérard GE
Int J Dermatol; 2011 Oct; 50(10):1234-9. PubMed ID: 21950289
[TBL] [Abstract][Full Text] [Related]
15. Phylloid hypomelanosis is closely related to mosaic trisomy 13.
Happle R
Eur J Dermatol; 2000; 10(7):511-2. PubMed ID: 11056419
[TBL] [Abstract][Full Text] [Related]
16. Novel neonatal presentation of megalencephaly-polymicrogyria-pigmentary mosaicism syndrome (MPPM) related to MTOR mutation: Report of a case.
Taylor DL; Wildin RS; Morley KW
Pediatr Dermatol; 2021 Mar; 38(2):536-537. PubMed ID: 33325571
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of two neurocutaneous syndromes: tuberous sclerosis and hypomelanosis of Ito.
Muhammed K; Mathew J
Indian J Dermatol Venereol Leprol; 2007; 73(1):43-5. PubMed ID: 17314448
[TBL] [Abstract][Full Text] [Related]
18. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes.
Taibjee SM; Bennett DC; Moss C
Br J Dermatol; 2004 Aug; 151(2):269-82. PubMed ID: 15327534
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma presenting in a child with hypomelanosis of Ito.
El-Sawy T; He L; Chiang MF; Anyane-Yeboa K; Morel KD; Folberg R; Marr BP; Abramson D
Open Ophthalmol J; 2011; 5():55-8. PubMed ID: 22216075
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
